INS and type 1 diabetes mellitus: Patients in the ND group had typically been treated with intravenous insulin usually for 2–3 d following diagnosis with T1D and prior to the initiation of IDet as part of a basal–bolus insulin regimen; 19.3% had experienced a hypoglycemic event during this period.